Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.7K Hold
28,880
0.02% 246
2026
Q1
$84.3K Sell
28,880
-2,700
-9% -$7.71K 0.02% 216
2025
Q4
$78K Hold
31,580
0.02% 223
2025
Q3
$70.4K Hold
31,580
0.02% 217
2025
Q2
$76.1K Sell
31,580
-2,900
-8% -$7.06K 0.02% 206
2025
Q1
$80.3K Hold
34,480
0.02% 201
2024
Q4
$63.8K Buy
34,480
+7,635
+28% +$16.9K 0.02% 208
2024
Q3
$65.5K Hold
26,845
0.02% 209
2024
Q2
$55K Hold
26,845
0.02% 204
2024
Q1
$66.6K Hold
26,845
0.02% 208
2023
Q4
$75.2K Hold
26,845
0.02% 205
2023
Q3
$69.3K Buy
26,845
+1,500
+6% +$4.34K 0.02% 197
2023
Q2
$80.6K Sell
25,345
-200
-0.8% -$588 0.03% 199
2023
Q1
$72K Sell
25,545
-1,785
-7% -$4.67K 0.02% 198
2022
Q4
$74.3K Sell
27,330
-1,500
-5% -$4.37K 0.03% 193
2022
Q3
$82K Sell
28,830
-850
-3% -$2.41K 0.03% 182
2022
Q2
$74K Sell
29,680
-1,200
-4% -$3.42K 0.02% 188
2022
Q1
$100K Sell
30,880
-2,000
-6% -$5.59K 0.03% 201
2021
Q4
$92K Buy
32,880
+3,000
+10% +$8.6K 0.02% 206
2021
Q3
$82K Sell
29,880
-3,000
-9% -$9.5K 0.02% 192
2021
Q2
$113K Buy
32,880
+4,265
+15% +$13.9K 0.03% 196
2021
Q1
$78K Buy
28,615
+2,050
+8% +$5.79K 0.02% 195
2020
Q4
$81K Hold
26,565
0.03% 183
2020
Q3
$60K Buy
26,565
+4,940
+23% +$12.4K 0.02% 177
2020
Q2
$57K Buy
21,625
+2,350
+12% +$5.54K 0.02% 169
2020
Q1
$44K Buy
+19,275
New +$69.7K 0.02% 157

Other funds holding ABEV

Roberts, Glore & Co's ABEV Position: Q2 2026 in Review

Roberts, Glore & Co held its Ambev (ABEV) position steady in Q2 2026 at 28,880 shares worth $90.7K. The position accounts for 0.02% of the portfolio, ranked #246.

Roberts, Glore & Co first reported a position in ABEV in Q1 2020 and has held it in 26 quarters since. The position peaked at $113K in Q2 2021. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Roberts, Glore & Co held 28,880 shares of Ambev worth $90.7K as of Q2 2026.
  • Roberts, Glore & Co left its Ambev share count unchanged in Q2 2026.
  • Ambev made up 0.02% of Roberts, Glore & Co's portfolio in Q2 2026, its #246 holding.
  • Roberts, Glore & Co first reported a position in Ambev in Q1 2020 and has held it in 26 quarters since.
  • Roberts, Glore & Co's Ambev position peaked at $113K in Q2 2021.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.